CD8A and neoplasm: In LV-ARsh xenografts, CD8+ T cells have higher expression of IFN-γ, TNF-α and perforin than those in non-transfected xenografts and LV-scramble xenografts, suggesting AR knockdown promoted anti-tumor activity of CD8+ T cells (Figure 5E).